Is tyrosinase evaluation an adequate and sensitive marker of blood metastatization in melanoma
Silvia Moretti(University of Insubria), B. Giannotti(University of Florence), Alessandra Chiarugi(University of Florence), Michele Piazzini(University of Florence), Iacopo Sardi(Meyer Children's Hospital), Margaret C. Pace(The University of Texas Southwestern Medical Center), Valeria De Giorgi(National Institutes of Health Clinical Center), R Guazzelli(Santa Maria Nuova Hospital)
Florence Research (University of Florence)
January 1, 1997
Cited by 0
Related Papers
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
|Nature Genetics|2016|362
New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions
|Pigment Cell Research|2002|298
Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001
|British Journal of Dermatology|2004|241
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
|International Journal of Molecular Sciences|2018|218